Literature DB >> 21817013

Mutations in CIC and FUBP1 contribute to human oligodendroglioma.

Chetan Bettegowda1, Nishant Agrawal, Yuchen Jiao, Mark Sausen, Laura D Wood, Ralph H Hruban, Fausto J Rodriguez, Daniel P Cahill, Roger McLendon, Gregory Riggins, Victor E Velculescu, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Bert Vogelstein, Darell Bigner, Hai Yan, Nickolas Papadopoulos, Kenneth W Kinzler.   

Abstract

Oligodendrogliomas are the second most common malignant brain tumor in adults and exhibit characteristic losses of chromosomes 1p and 19q. To identify the molecular genetic basis for this alteration, we performed exomic sequencing of seven tumors. Among other changes, we found that the CIC gene (homolog of the Drosophila gene capicua) on chromosome 19q was somatically mutated in six cases and that the FUBP1 gene [encoding far-upstream element (FUSE) binding protein] on chromosome 1p was somatically mutated in two tumors. Examination of 27 additional oligodendrogliomas revealed 12 and 3 more tumors with mutations of CIC and FUBP1, respectively, 58% of which were predicted to result in truncations of the encoded proteins. These results suggest a critical role for these genes in the biology and pathology of oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21817013      PMCID: PMC3170506          DOI: 10.1126/science.1210557

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  25 in total

1.  Relief of gene repression by torso RTK signaling: role of capicua in Drosophila terminal and dorsoventral patterning.

Authors:  G Jiménez; A Guichet; A Ephrussi; J Casanova
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

2.  Molecular genetic evidence for subtypes of oligoastrocytomas.

Authors:  D Maintz; K Fiedler; J Koopmann; B Rollbrocker; S Nechev; D Lenartz; A P Stangl; D N Louis; J Schramm; O D Wiestler; A von Deimling
Journal:  J Neuropathol Exp Neurol       Date:  1997-10       Impact factor: 3.685

3.  The genetics of childhood cancer.

Authors:  A G Knudson
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

4.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2011-06-05       Impact factor: 49.962

5.  Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas.

Authors:  S W Coons; P C Johnson; B W Scheithauer; A J Yates; D K Pearl
Journal:  Cancer       Date:  1997-04-01       Impact factor: 6.860

6.  CIC, a gene involved in cerebellar development and ErbB signaling, is significantly expressed in medulloblastomas.

Authors:  Ching-Jung Lee; Wai-In Chan; Paul J Scotting
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

7.  A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif.

Authors:  R Duncan; L Bazar; G Michelotti; T Tomonaga; H Krutzsch; M Avigan; D Levens
Journal:  Genes Dev       Date:  1994-02-15       Impact factor: 11.361

Review 8.  Hereditary cancer: two hits revisited.

Authors:  A G Knudson
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

9.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

Authors:  S J Baker; E R Fearon; J M Nigro; S R Hamilton; A C Preisinger; J M Jessup; P vanTuinen; D H Ledbetter; D F Barker; Y Nakamura; R White; B Vogelstein
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

10.  EGFR signalling inhibits Capicua-dependent repression during specification of Drosophila wing veins.

Authors:  Fernando Roch; Gerardo Jiménez; Jordi Casanova
Journal:  Development       Date:  2002-02       Impact factor: 6.868

View more
  218 in total

Review 1.  Delving into somatic variation in sporadic melanoma.

Authors:  Vijay Walia; Euphemia W Mu; Jimmy C Lin; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

2.  Oligodendrogliomas: a short history of clinical developments.

Authors:  Martin J van den Bent
Journal:  CNS Oncol       Date:  2015

3.  CIC-DUX4 Induces Small Round Cell Sarcomas Distinct from Ewing Sarcoma.

Authors:  Toyoki Yoshimoto; Miwa Tanaka; Mizuki Homme; Yukari Yamazaki; Yutaka Takazawa; Cristina R Antonescu; Takuro Nakamura
Journal:  Cancer Res       Date:  2017-04-12       Impact factor: 12.701

Review 4.  The evolving molecular genetics of low-grade glioma.

Authors:  Sriram Venneti; Jason T Huse
Journal:  Adv Anat Pathol       Date:  2015-03       Impact factor: 3.875

5.  Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas.

Authors:  Agustí Alentorn; Hinke F van Thuijl; Yannick Marie; Hussa Alshehhi; Catherine Carpentier; Blandine Boisselier; Florence Laigle-Donadey; Karima Mokhtari; Ilari Scheinin; Pieter Wesseling; Bauke Ylstra; Laurent Capelle; Khê Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Jaap C Reijneveld; Ahmed Idbaih
Journal:  Neuro Oncol       Date:  2013-12-12       Impact factor: 12.300

6.  Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas.

Authors:  Agustí Alentorn; Caroline Dehais; François Ducray; Catherine Carpentier; Karima Mokhtari; Dominique Figarella-Branger; Olivier Chinot; Elisabeth Cohen-Moyal; Carole Ramirez; Hugues Loiseau; Selma Elouahdani-Hamdi; Patrick Beauchesne; Olivier Langlois; Christine Desenclos; Jean-Sébastien Guillamo; Phong Dam-Hieu; François Ghiringhelli; Philippe Colin; Joel Godard; Fabrice Parker; Frédéric Dhermain; Antoine F Carpentier; Jean-Sebastien Frenel; Philippe Menei; Luc Bauchet; Thierry Faillot; Mélanie Fesneau; Denys Fontaine; Marie-Jeannette Motuo-Fotso; Elodie Vauleon; Claude Gaultier; Caroline Le Guerinel; Edouard-Marcel Gueye; Georges Noel; Nicolas Desse; Xavier Durando; Eduardo Barrascout; Michel Wager; Damien Ricard; Ioana Carpiuc; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Neurology       Date:  2015-09-18       Impact factor: 9.910

Review 7.  Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.

Authors:  Michael Weller; Roger Stupp; Monika E Hegi; Martin van den Bent; Joerg C Tonn; Marc Sanson; Wolfgang Wick; Guido Reifenberger
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

8.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

9.  ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.

Authors:  Cody L Nesvick; Chao Zhang; Nancy A Edwards; Blake K Montgomery; Michaela Lee; Chunzhang Yang; Herui Wang; Dongwang Zhu; John D Heiss; Marsha J Merrill; Abhik Ray-Chaudhury; Zhengping Zhuang
Journal:  J Neurooncol       Date:  2016-08-27       Impact factor: 4.130

10.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.

Authors:  Patrick J Killela; Zachary J Reitman; Yuchen Jiao; Chetan Bettegowda; Nishant Agrawal; Luis A Diaz; Allan H Friedman; Henry Friedman; Gary L Gallia; Beppino C Giovanella; Arthur P Grollman; Tong-Chuan He; Yiping He; Ralph H Hruban; George I Jallo; Nils Mandahl; Alan K Meeker; Fredrik Mertens; George J Netto; B Ahmed Rasheed; Gregory J Riggins; Thomas A Rosenquist; Mark Schiffman; Ie-Ming Shih; Dan Theodorescu; Michael S Torbenson; Victor E Velculescu; Tian-Li Wang; Nicolas Wentzensen; Laura D Wood; Ming Zhang; Roger E McLendon; Darell D Bigner; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Hai Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.